Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:23 AM
Ignite Modification Date:
2025-12-25 @ 1:23 AM
NCT ID:
NCT03869593
Eligibility Criteria:
Inclusion Criteria:
* Patient with S. aureus or E. coli bacteriostatic bacteremia defined by at least one positive blood culture bottle
* Patient requiring a blood test as part of his bacteremia
* not subject to a judicial protection measure
* Signature of the non-opposition of consent (for minor patients signed by one of the parents or the representative of the parental authority)
* Affiliation to social security
Exclusion Criteria:
* Immunocompromised patient defined by:
* current immunosuppressive therapies: corticosteroids, chemotherapy, biotherapy
* solid organ transplant patient or hematopoietic stem cell transplant
* chemotherapy-induced neutropenia
* Congenital immune deficiency
* bacteremia related to a peripheral or central catheter
* Urinary obstruction not lifted within the first 24 hours of management
* Intra-abdominal infection collected undrained in the first 24 hours of management
* primary infectious focus represented by mechanically ventilated pneumonia
* Pregnant or lactating woman
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
8 Years
Maximum Age:
75 Years
Study:
NCT03869593
Study Brief:
Protocol Section:
NCT03869593